Demystifying Stem Cell Transplant for Multiple Myeloma Treatment

Demystifying Stem Cell Transplant for Multiple Myeloma Treatment

In 2017 stem cell transplants remains a key option for treatment of eligible multiple myeloma patients, and in majority of patients it is done as a part of frontline therapy. Research shows that stem cell transplants significantly increases the amount of time, for which a patient has their disease under control. How safe are transplants? Who is eligible to get one? What are the side effects and how can patients tackle them? The myeloma panel is talking to Dr. Rafael Fonseca for answers to these and more on the latest developments in stem cell transplant technology in multiple myeloma treatment.


Talk Recorded on Oct. 4, 2017, 5 p.m. EST 1295 </> Embed

Hear Talk Audio

  • Anonymous User Dec. 12, 2017, 8:30 p.m.  US/Eastern

    Have drugs replaced the need for ASCT?

  • Anonymous User Oct. 4, 2017, 4:58 p.m.  US/Eastern

    Today is the 8th anniversary of going in for my ASCT. That along with maintenance dosages kept me almost cancer free for 6+ years. If transplant was so successful, should I consider another one if needed? (62 in a month).

  • Anonymous User Oct. 4, 2017, 5:42 a.m.  US/Eastern

    After Transplant, maintenance or not?

  • Anonymous User Oct. 4, 2017, 5:42 a.m.  US/Eastern

    I have tried two times to collect stem cells during the past 6 months. I go next week to try again. The first time, I got 4.6 million but the second time they did not get enough to try apheresis. Do you have any advice so that I can collect this time?

  • Anonymous User Oct. 4, 2017, 5:40 a.m.  US/Eastern

    Is it best to be at a point where you are in some form of remission before transplanting. I have also seen where many centers look for there to be at least a 90% decrease in your mspike number do you agree with that?

  • Anonymous User Oct. 4, 2017, 5:39 a.m.  US/Eastern

    How is the decision to do a donor transplant made? Why are donor transplants more risky for myeloma patients than other cancers? Are strides being made to achieve better survival statistics?

  • Anonymous User Oct. 4, 2017, 5:38 a.m.  US/Eastern

    With the new drugs and treatments, why do we continue to use transplants as line of therapy?

  • Anonymous User Oct. 4, 2017, 5:38 a.m.  US/Eastern

    What lab values or other tests such as bone marrow biopsy indicate relapse and the time to start treatment again? At relapse, what chemotherapy should be utilized and at what point should a second transplant be done, particularly if there has been a complete response or very good partial response for a period of 2 years or more following an initial VRD induction chemotherapy and autologous stem cell transplant without maintenance therapy?

  • Anonymous User Sept. 20, 2017, 11:52 a.m.  US/Eastern

    Will there be any discussion on allogeneic transplants?

    Show / Hide Replies

    Priya Menon Oct. 4, 2017, 2:02 a.m.  US/Eastern

    Reply: Hi, yes. You can ask your question on -air or post it here and we will get it answered by the doctor. Thanks.